Table 3.

Evaluation of the total number of colonies derived from hematopoietic (CFU-hem's) and endothelial progenitor cells (CFU-end's) obtained by in vitro cultured PBMCs from patients with AMI at T0, patients with SA, and healthy CTRLs

AMI (T0), n = 7
SA, n = 7
CTRLs, n = 7
CFU-hem's  202 (94-250)*  44 (0-189)   86 (13-100)  
    CFU-GMs   90 (36-108)*  18 (0-100)   34 (5-42)  
    BFU-Es   94 (59-150)*  26 (0-88)   52 (8-60)  
CFU-end's
 		 39 (20-57)†
 		 21 (12-35)
 		 21 (8-26)
 
AMI (T0), n = 7
SA, n = 7
CTRLs, n = 7
CFU-hem's  202 (94-250)*  44 (0-189)   86 (13-100)  
    CFU-GMs   90 (36-108)*  18 (0-100)   34 (5-42)  
    BFU-Es   94 (59-150)*  26 (0-88)   52 (8-60)  
CFU-end's
 		 39 (20-57)†
 		 21 (12-35)
 		 21 (8-26)
 

The number of committed erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells is also shown. The results, expressed as number of CFU-hem/5 × 105 PBMCs or number of CFU-end/106 PBMCs, are shown as median (range).

*

P ≤ .03 versus CTRLs.

†

P < .05 versus CTRLs.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal